Overview
Philippe Glorennec practices practicing medicine in Rennes, France.
Mr. Glorennec is highly rated in 1 condition, according to our data. His clinical expertise encompasses Heavy Metal Poisoning and Neurotoxicity Syndromes.
He is actively involved in clinical research, co-authoring 51 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Philippe Glorennec
Is Philippe Glorennec a top-rated expert for Heavy Metal Poisoning?
MediFind is an objective health platform that identifies experts based on real-world data. Philippe Glorennec is classified as an Advanced expert for Heavy Metal Poisoning, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Philippe Glorennec participate in research or clinical trials?
Yes. Philippe Glorennec has published 51 articles and abstracts on conditions like Heavy Metal Poisoning. You can view a list of Philippe Glorennec's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Heavy Metal PoisoningMr. Glorennec isAdvanced. Learn about Heavy Metal Poisoning.
- Experienced
- Neurotoxicity SyndromesMr. Glorennec isExperienced. Learn about Neurotoxicity Syndromes.